| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Gilead Sciences Inc (NASDAQ: GILD)
GILD Technical Analysis
5
| As on 3rd Dec 2025 GILD SHARE Price closed @ 125.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 107.56 & Strong Buy for SHORT-TERM with Stoploss of 94.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GILDSHARE Price
| Open | 124.21 | Change | Price | % |
| High | 125.60 | 1 Day | 1.09 | 0.88 |
| Low | 123.88 | 1 Week | -1.64 | -1.30 |
| Close | 125.00 | 1 Month | 0.92 | 0.74 |
| Volume | 4953086 | 1 Year | 32.42 | 35.02 |
| 52 Week High 128.07 | 52 Week Low 89.14 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| IRBT | 3.39 | 73.85% |
| NVDA | 179.59 | -1.03% |
| ONDS | 8.92 | 10.53% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.23 | 5.69% |
| AKTS | 0.04 | 0.00% |
| TSLA | 446.74 | 4.08% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GILD Daily Charts |
GILD Intraday Charts |
Whats New @ Bazaartrend |
GILD Free Analysis |
|
|
GILD Important Levels Intraday
| RESISTANCE | 128.31 |
| RESISTANCE | 127.25 |
| RESISTANCE | 126.59 |
| RESISTANCE | 125.94 |
| SUPPORT | 124.06 |
| SUPPORT | 123.41 |
| SUPPORT | 122.75 |
| SUPPORT | 121.69 |
GILD Forecast December 2025
| 4th UP Forecast | 136.68 |
| 3rd UP Forecast | 132.93 |
| 2nd UP Forecast | 130.62 |
| 1st UP Forecast | 128.3 |
| 1st DOWN Forecast | 121.7 |
| 2nd DOWN Forecast | 119.38 |
| 3rd DOWN Forecast | 117.07 |
| 4th DOWN Forecast | 113.32 |
GILD Weekly Forecast
| 4th UP Forecast | 135.58 |
| 3rd UP Forecast | 132.19 |
| 2nd UP Forecast | 130.09 |
| 1st UP Forecast | 127.99 |
| 1st DOWN Forecast | 122.01 |
| 2nd DOWN Forecast | 119.91 |
| 3rd DOWN Forecast | 117.81 |
| 4th DOWN Forecast | 114.42 |
GILD Forecast2025
| 4th UP Forecast | 202.31 |
| 3rd UP Forecast | 177.52 |
| 2nd UP Forecast | 162.19 |
| 1st UP Forecast | 146.87 |
| 1st DOWN Forecast | 103.13 |
| 2nd DOWN Forecast | 87.81 |
| 3rd DOWN Forecast | 72.48 |
| 4th DOWN Forecast | 47.69 |
Gilead Sciences Inc ( NASDAQ USA Symbol : GILD )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GILD Business Profile
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California. Address: 333 Lakeside Drive, Foster City, CA, United States, 94404
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service